Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Connective tissue diseases: Is combined oral contraceptive use linked to SLE incidence?

Literature DB >> 19568249

Connective tissue diseases: Is combined oral contraceptive use linked to SLE incidence?

Chi Chiu Mok.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2009 PMID： 19568249 DOI： 10.1038/nrrheum.2009.118

Source DB: PubMed Journal: Nat Rev Rheumatol ISSN： 1759-4790 Impact factor: 20.543

Keyword Cloud
References

× No keyword cloud information.

10 in total

1. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial.

Authors: Jill P Buyon; Michelle A Petri; Mimi Y Kim; Kenneth C Kalunian; Jennifer Grossman; Bevra H Hahn; Joan T Merrill; Lisa Sammaritano; Michael Lockshin; Graciela S Alarcón; Susan Manzi; H Michael Belmont; Anca D Askanase; Lisa Sigler; Mary Anne Dooley; Joan Von Feldt; W Joseph McCune; Alan Friedman; Jane Wachs; Mary Cronin; Michelene Hearth-Holmes; Mark Tan; Frederick Licciardi
Journal: Ann Intern Med Date: 2005-06-21 Impact factor: 25.391

2. Past use of oral contraceptives and the risk of developing systemic lupus erythematosus.

Authors: J Sanchez-Guerrero; E W Karlson; M H Liang; D J Hunter; F E Speizer; G A Colditz
Journal: Arthritis Rheum Date: 1997-05

3. Combined oral contraceptives in women with systemic lupus erythematosus.

Authors: Michelle Petri; Mimi Y Kim; Kenneth C Kalunian; Jennifer Grossman; Bevra H Hahn; Lisa R Sammaritano; Michael Lockshin; Joan T Merrill; H Michael Belmont; Anca D Askanase; W Joseph McCune; Michelene Hearth-Holmes; Mary Anne Dooley; Joan Von Feldt; Alan Friedman; Mark Tan; John Davis; Mary Cronin; Betty Diamond; Meggan Mackay; Lisa Sigler; Michael Fillius; Ann Rupel; Frederick Licciardi; Jill P Buyon
Journal: N Engl J Med Date: 2005-12-15 Impact factor: 91.245

4. A trial of contraceptive methods in women with systemic lupus erythematosus.

Authors: Jorge Sánchez-Guerrero; América G Uribe; Luisa Jiménez-Santana; Marilú Mestanza-Peralta; Pilar Lara-Reyes; Armando H Seuc; María-del-Carmen Cravioto
Journal: N Engl J Med Date: 2005-12-15 Impact factor: 91.245

5. Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome.

Authors: N Guballa; L Sammaritano; S Schwartzman; J Buyon; M D Lockshin
Journal: Arthritis Rheum Date: 2000-03

6. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

Authors: N Kanda; T Tsuchida; K Tamaki
Journal: Arthritis Rheum Date: 1999-02

Connective tissue diseases: Is combined oral contraceptive use linked to SLE incidence?

1. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial.

2. Past use of oral contraceptives and the risk of developing systemic lupus erythematosus.

3. Combined oral contraceptives in women with systemic lupus erythematosus.

4. A trial of contraceptive methods in women with systemic lupus erythematosus.

5. Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome.

6. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

Review 7. Pathogenesis of systemic lupus erythematosus.

8. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.

9. Association of the oestrogen receptor alpha gene polymorphisms with disease onset in systemic lupus erythematosus.

10. Combined oral contraceptive use and the risk of systemic lupus erythematosus.